Poseida Therapeutics

Matthew Spear, M.D., Chief Medical Officer

Oct. 13 | 5:30pm | AVROBIO Ballroom

San Diego, CA

(NASDAQ: PSTX)

In-person Presentation

Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging proprietary next-generation, non-viral gene engineering technologies to create ground-breaking, life-saving cell and gene therapies for patients with high unmet medical need. At Poseida, we are using our broad gene engineering platform technologies to bring new and better treatments to patients with serious diseases – blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver.

www.poseida.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions